Peptide Therapy & Growth Hormone

This is the category where marketing most outruns evidence. Prescribing human growth hormone (HGH) for "anti-aging" is prohibited under US federal law (21 U.S.C. § 333(e)) — HGH may only be distributed for specific FDA-approved conditions such as confirmed adult growth hormone deficiency. Popular "peptide" alternatives (sermorelin, ipamorelin, CJC-1295) are compounded products that are not FDA-approved, and the U.S. Food & Drug Administration (FDA) has flagged several of them over compounding safety concerns.

Peptide Therapy & Growth Hormone

We track 440 verified clinics offering Peptide Therapy & Growth Hormone across our directory. Across 12 clinics with published pricing, cash-pay Peptides & HGH programs report a median range around $199-$399/mo. Nationally, secretagogue peptide programs run $200–$500/mo cash-pay, while legitimate HGH for diagnosed deficiency runs $500–$1,500+/mo. Average public Google rating across 421 rated clinics: 4.7★ from 22,231 reviews.

Updated 2026-08-15. Cost figures are estimates, not quotes. See the full year-one cost breakdown.

Diagnostic Biomarker & Clinical Prerequisite Summary

How many clinics offer Peptide Therapy & Growth Hormone?

Our directory currently tracks 440 verified clinics offering Peptide Therapy & Growth Hormone. This is the category where marketing most outruns evidence. Prescribing human growth hormone (HGH) for "anti-aging" is prohibited under US federal law (21 U.S.C. § 333(e)) — HGH may only be distributed for specific FDA-approved conditions such as confirmed adult growth hormone deficiency. Popular "peptide" alternatives (sermorelin, ipamorelin, CJC-1295) are compounded products that are not FDA-approved, and the U.S. Food & Drug Administration (FDA) has flagged several of them over compounding safety concerns.

The legal line most clinics won't explain

HGH (somatropin) occupies a unique place in US law: under 21 U.S.C. § 333(e), distributing or possessing it with intent to distribute for any use other than an FDA-approved indication is a federal offense. Approved uses include confirmed adult growth hormone deficiency (diagnosed by stimulation testing), HIV-associated wasting, and several pediatric conditions. "Anti-aging," "wellness," and "optimization" are not approved uses — a clinic offering HGH for those purposes is describing an illegal prescription.

That legal wall is why the longevity industry pivoted to growth hormone secretagogues — peptides like sermorelin, ipamorelin, and CJC-1295 that stimulate your pituitary to release its own growth hormone. These are typically compounded, which means no FDA review of efficacy, dosing, or purity, and the U.S. Food & Drug Administration (FDA) has placed several popular peptides in its highest-concern category for compounding due to safety uncertainties.

What the evidence actually shows

The study that launched the anti-aging GH industry — Rudman's 1990 New England Journal of Medicine trial in 12 older men — showed increased lean mass and decreased fat over six months. What marketing omits: a 2007 systematic review in Annals of Internal Medicine of GH in the healthy elderly found the body-composition changes were modest, functional benefits were unproven, and side effects were common — soft-tissue edema, joint pain, carpal tunnel syndrome, and increased rates of impaired glucose tolerance and diabetes.

For secretagogue peptides, controlled long-term outcome data in healthy adults are thinner still. Short-term studies show increased GH pulses and IGF-1; translation into meaningful, safe long-term benefit is unproven. Where no governing body or settled guideline exists for a treatment or claim, we state that explicitly — anyone claiming peptides are a proven longevity intervention is ahead of the science.

If you're still considering it

• Rule out true growth hormone deficiency properly: stimulation testing through an endocrinologist, not a single IGF-1 reading used as a sales tool
• Ask exactly which pharmacy compounds the product, in which state it is licensed, and request a certificate of analysis
• Avoid any 'research chemical' or online peptide vendor — purity and dosing are unverifiable
• Monitor fasting glucose and A1c — GH elevation degrades insulin sensitivity
• Budget $200–$500/month for typical secretagogue programs and treat claims of 'reversing aging' as marketing

How much does Peptide Therapy & Growth Hormone cost?

Across 12 clinics with cited published pricing, reported cash prices for Peptides & HGH median at $199-$399/mo.

Which clinics offer Peptide Therapy & Growth Hormone?

What clinical guidelines and risks govern Peptide Therapy & Growth Hormone?

Important: HGH cannot legally be prescribed for anti-aging in the United States under 21 U.S.C. § 333(e). Peptide secretagogues are not FDA-approved, and several have been flagged by the FDA over compounding safety concerns. This page exists so you can evaluate these programs with the legal and evidence context most marketing leaves out. The study that launched the anti-aging GH industry — Rudman's 1990 New England Journal of Medicine trial in 12 older men — showed increased lean mass and decreased fat over six months. What marketing omits: a 2007 systematic review in Annals of Internal Medicine of GH in the healthy elderly found the body-composition changes were modest, functional benefits were unproven, and side effects were common — soft-tissue edema, joint pain, carpal tunnel syndrome, and increased rates of impaired glucose tolerance and diabetes. For secretagogue peptides, controlled long-term outcome data in healthy adults are thinner still. Short-term studies show increased GH pulses and IGF-1; translation into meaningful, safe long-term benefit is unproven. Where no governing body or settled guideline exists for a treatment or claim, we state that explicitly — anyone claiming peptides are a proven longevity intervention is ahead of the science.

Frequently Asked Questions

Is HGH legal for anti-aging?

No. Federal law (21 U.S.C. § 333(e)) prohibits distributing HGH for anything other than FDA-approved indications such as confirmed adult growth hormone deficiency or HIV-associated wasting. Anti-aging and wellness use is explicitly outside the law, regardless of what a clinic's marketing implies.

Are peptides like sermorelin and ipamorelin FDA-approved?

No. They are compounded products without FDA review of safety, efficacy, or dose consistency. The U.S. Food & Drug Administration (FDA) has placed several popular peptides in its highest-concern category for compounding, citing safety uncertainties. Legality of compounding varies by peptide and pharmacy type.

What's the difference between HGH and peptide secretagogues?

HGH is the hormone itself, injected directly. Secretagogues (sermorelin, ipamorelin, CJC-1295) prompt your pituitary to release more of your own GH. Secretagogues produce smaller, more physiologic GH elevations — and correspondingly smaller effects — with less regulatory restriction but also far less evidence.

How much does peptide therapy cost?

Typical clinic programs run $200–$500/month depending on the peptide stack and monitoring included. Legitimate HGH therapy for diagnosed deficiency, dosed properly, often exceeds $500–$1,500/month and requires endocrinology-grade workup.

What is BPC-157 and does it work?

BPC-157 is a synthetic peptide popular for injury recovery claims. Human trial evidence is essentially absent — the enthusiasm rests on animal studies — and the FDA has flagged it among peptides with safety concerns for compounding. Treat it as experimental.

What are the side effects of raising growth hormone?

In studies of GH in healthy older adults (Annals of Internal Medicine systematic review, 2007): fluid retention and swelling, joint pain, carpal tunnel syndrome, and impaired glucose tolerance progressing to diabetes in some users. Long-term cancer-risk questions remain unresolved. Secretagogues share these concerns in proportion to the GH elevation achieved.

How is real growth hormone deficiency diagnosed?

With growth hormone stimulation testing (such as glucagon or macimorelin testing) interpreted by an endocrinologist, usually in the context of pituitary disease, surgery, or radiation. A low-normal IGF-1 level alone — the common med-spa screening tool — does not establish deficiency.

Why do so many clinics sell peptides if the evidence is weak?

Margins are high, the products feel cutting-edge, and the legal restrictions on HGH pushed demand toward less-regulated alternatives. That's precisely why this directory flags peptide-heavy clinics for extra due diligence — ask for the evidence, the pharmacy's credentials, and the monitoring plan.

Browse all Peptides & HGH clinics

References & Recognized Medical Board Citations

Directory clinical prerequisites, baseline bloodwork guidelines, and treatment protocols listed on VerifiedAntiAgingClinics.com align with published clinical practice guidelines established by recognized national medical boards and professional societies, including the American Board of Obesity Medicine (ABOM), American Board of Urology (ABU), American Board of Internal Medicine - Endocrinology (ABIM), The Endocrine Society, The Menopause Society, and the American Urological Association (AUA).

1. Effects of Human Growth Hormone in Men over 60 Years Old (Rudman et al., 1990) — New England Journal of Medicine
2. Systematic Review: The Safety and Efficacy of Growth Hormone in the Healthy Elderly (Liu et al., 2007) — Annals of Internal Medicine (PubMed)
3. 21 U.S.C. § 333(e) — federal restrictions on human growth hormone distribution — U.S. Code (Cornell Law School LII)
4. Human Drug Compounding: FDA oversight and bulk substance evaluations — U.S. Food & Drug Administration

Page updated 2026-08-15. Ratings and review counts are aggregated from public Google Business Profiles and are not our own reviews.